Using vibration therapy to improve voice disorders caused by muscle tension
Translaryngeal Vibration for Hyperfunctional Voice Disorders
This study is exploring a new way to help people with voice problems, like muscle tension dysphonia, by using gentle vibrations around the voice box to improve their voice quality and recovery, making therapy more effective and personalized for each participant.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Christian University NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-10914391 on NIH RePORTER |
What this research studies
This research investigates the use of local translaryngeal vibration therapy (LTLV) as a treatment for hyperfunctional voice disorders, particularly muscle tension dysphonia (MTD). The approach involves applying vibration to the area around the larynx to enhance voice quality and rehabilitation outcomes. By refining voice therapy techniques, the study aims to address the limitations of current treatments and improve the effectiveness of voice therapy for patients. Participants will receive tailored therapy sessions that incorporate this innovative vibration technique.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with muscle tension dysphonia or other hyperfunctional voice disorders.
Not a fit: Patients with voice disorders not related to muscle tension or those who do not respond to behavioral voice therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for individuals suffering from voice disorders, improving their quality of life and communication abilities.
How similar studies have performed: Preliminary studies have shown promising results for vibration therapy in voice rehabilitation, indicating potential for success in this novel approach.
Where this research is happening
Fort Worth, United States
- Texas Christian University — Fort Worth, United States (Active)
Researchers
- Principal investigator: Watts, Christopher R. — Texas Christian University
- Study coordinator: Watts, Christopher R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.